ÂÜÀòÂÒÂ×

Nicholas Franco is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Chairman of the Board and a member of the Board of Directors at Immune Biosolutions Inc., as well as a member of the Board of Advisors at Eyam Vaccines and Immunotherapeutics, Nicholas also contributes to McGill University’s Corporate Engagement Committee within the Faculty of Medicine & Health Sciences. Prior roles include EVP and Chief Business Development Officer at The Janssen Pharmaceutical Companies of Johnson & Johnson and Actelion, Senior Vice-President at Axcan Pharma SAS, and various leadership positions at Novartis Pharma AG. Nicholas holds an MBA in Strategic Marketing and a BSc in Biochemistry, both from McGill University.